Literature DB >> 19628909

Erroneous reporting of vancomycin susceptibility for Staphylococcus spp. by Vitek software version 2.01.

Bijayini Behera1, Purva Mathur.   

Abstract

The reporting of vancomycin resistance in Staphylococcus spp. has enormous therapeutic and epidemiological consequences. We evaluated Vitek software version 2.01 by the CLSI-recommended broth dilution method as well as the CDC-recommended vancomycin screen agar and Etest for vancomycin susceptibility testing of Staphylococcus spp. Of the 105 isolates of Staphylococci tested by the above methods, Vitek 2.01 gave 16 (15%) a false vancomycin intermediate/resistant phenotype. Laboratories using automated systems for routine microbiological susceptibility testing must confirm such resistance by validated methods.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19628909

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN： 1344-6304            Impact factor:   1.362


  4 in total

Review 1.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  Methicillin Resistant Staphylococcus aureus: Inconsistencies in Vancomycin Susceptibility Testing Methods, Limitations and Advantages of each Method.

Authors:  Charu Agrawal; Molly Madan; Anita Pandey; Bhaskar Thakuria
Journal:  J Clin Diagn Res       Date:  2015-10-01

3.  Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad.

Authors:  Venubabu Thati; Channappa T Shivannavar; Subhaschandra M Gaddad
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

4.  Trend of vancomycin susceptibility of staphylococci at a level 1 trauma centre of India.

Authors:  Neetu Jain; Purva Mathur; M C Misra
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.